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Abstract
Peripheral blood T-cells from untreated HIV-1-infected patients exhibit reduced immune responses, usually associated with
a hyperactivated/exhausted phenotype compared to HAART treated patients. However, it is not clear whether HAART
ameliorates this altered phenotype of T-cells in the gastrointestinal-associated lymphoid tissue (GALT), the main site for viral
replication. Here, we compared T-cells from peripheral blood and GALT of two groups of chronically HIV-1-infected patients:
untreated patients with active viral replication, and patients on suppressive HAART. We characterized the T-cell phenotype
by measuring PD-1, CTLA-4, HLA-DR, CD25, Foxp3 and granzyme A expression by flow cytometry; mRNA expression of T-
bet, GATA-3, ROR-ct and Foxp3, and was also evaluated in peripheral blood mononuclear cells and rectal lymphoid cells. In
HIV-1+ patients, the frequency of PD-1
+ and CTLA-4
+ T-cells (both CD4+ and CD8+ T cells) was higher in the GALT than in
the blood. The expression of PD-1 by T-cells from GALT was higher in HIV-1-infected subjects with active viral replication
compared to controls. Moreover, the expression per cell of PD-1 and CTLA-4 in CD4
+ T-cells from blood and GALT was
positively correlated with viral load. HAART treatment decreased the expression of CTLA-4 in CD8
+ T cells from blood and
GALT to levels similar as those observed in controls. Frequency of Granzyme A
+ CD8
+ T-cells in both tissues was low in the
untreated group, compared to controls and HAART-treated patients. Finally, a switch towards Treg polarization was found
in untreated patients, in both tissues. Together, these findings suggest that chronic HIV-1 infection results in an activated/
exhausted T-cell phenotype, despite T-cell polarization towards a regulatory profile; these alterations are more pronounced
in the GALT compared to peripheral blood, and are only partiality modulated by HAART.
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Introduction
During the acute phase of human immunodeficiency virus type
1 (HIV-1) infection, the gastrointestinal-associated lymphoid tissue
(GALT) suffers the most substantial immunological and structural
damage due to massive elimination of CD4
+CCR5
+ T-cells, as a
result of high levels of viral replication [1,2]. This event leads to
microbial product translocation from the lumen of the gastroin-
testinal tract to systemic circulation [3,4], contributing to the
establishment of chronic immune activation [5]. Concomitantly,
there is a progressive loss of the regenerative capacity of the
lymphoid tissue [6]. Alteration of antigen-presenting cells and T-
cells are distinctive; in particular, reduced proliferation and
cytokine production by T-cells occurs in response to different
stimuli. Many of these defects persist in patients receiving highly
active antiretroviral therapy (HAART) [7,8].
HLA-DR, CD25 and granzymes are molecules associated with
activation and effector functions of CD8 T-cells. Indeed, activation
of cytotoxic T-cells has been correlated with the control of viral
replication, and is one of the best predictors of disease progression
[9]. Other markers such as programmed death 1 (PD-1) and the
cytotoxic T-lymphocyte antigen 4 (CTLA-4) are classically
associated with activation, and persistence of high levels of
expression of these markers by peripheral blood T cells of
untreated patients is linked to T-cell exhaustion [10]. PD-1 and
CTLA-4 upregulation appear closely linked to HIV replication
and progressive disease; in fact, specific blockage of these pathways
with monoclonal antibodies enhances HIV-1-specific T-cell
responses [11,10].
Although HAART has significantly improved the quality of life
of HIV-1-infected patients and particularly their life expectancy,
incomplete suppression of viral replication and partial restoration
of CD4
+ T-cells are often seen in GALT, in contrast to peripheral
blood, despite continuous use of HAART [12]. Since GALT is a
highly regulated tissue and the main site of HIV-1 replication, a
detailed phenotypic characterization of its T-cell subsets and their
modulation by HAART, is important to better understand HIV-1
pathogenesis.
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30307Considering that GALT disruption induces T-cell activation/
exhaustion, in parallel with regulatory processes that are
associated with the inability of the immune system to mount
effective responses against HIV-1 and other pathogens [13,14],
we were interested in characterizing the immune response in
GALT. Our results suggest that HIV-1 infection induces a
pattern of T cell activation/exhaustion, affecting both CD4
+ and
CD8
+ T cells, despite increased polarization towards a
regulatory profile. These changes are clearer in GALT than in
peripheral blood. Importantly, HAART does not totally normal-
iza this phenotype.
Results
Patient characteristics
As shown in Table 1, groups were matched by age. The
macroscopic evaluation of rectosigmoidoscopies was normal in all
individuals. No evidence of active opportunistic infections and
tumors was detected in any of the HIV-1-infected subjects at the
time of sampling. Patients on HAART (H) had been on
antiretroviral therapy for a median of 9 (6-13) years; all patients
except 2 had an absolute CD4
+ T-cell count above 300 cells/
mm
3. In this group, 62% (8/13 patients) presented an
undetectable viral load (VL; ,40 copies/ml), 31% (4/13 patients)
had ,290 copies/ml, and 1 patient had a VL.1,000 copies/ml
(1,193 copies/ml) at the time of sampling. 80% of the untreated
patients (U) had CD4 counts .250 cells/mm
3 and 70% of them
had a VL.20,000 copies/ml. As expected, the median VL of the
untreated group was significantly higher than that of the treated
group (p,0.001). The percentage and absolute counts of CD8
+
T-cells were high in all infected individuals compared to controls
(C), with the highest values found in the untreated group
(Table 1).
To evaluate the efficacy of HAART on the reconstitution of
CD4
+ T cells, we determined the CD4
+/CD8
+ Tc e l lr a t i oi n
both peripheral blood and GALT. In controls, the CD4
+/CD8
+
T cell ratio in blood was 2.22 (1.22-2.87); however, in normal
GALT the frequency of CD4
+ and CD8
+ T cells was similar with
a ratio of 1.26 (0.63-2.37). On HIV-1+ patients, the depletion of
CD4
+ T cells is clear in both compartments; with a incomplete
reconstitution even after prolonged suppressive therapy on
PMBC (H:0.47 vs C: 2.22; p,0.01) and GALT (H:0.34 vs C:
1.26; p,0.01). The CD4
+/CD8
+ T cell ratio was strikingly low
on the untreated group, with a ratio of 0.30 (0.004-0.69) (U vs C;
p,0.001) and 0.14 (0.03-0.29) (U vs C; p,0.001) in PBMC and
GALT, respectively.
GALT T-cells from untreated HIV-1-infected patients
express high levels of molecules associated with immune
activation and exhaustion
An important hallmark of chronic HIV-1 infection is the
immune activation, which leads to T-cell exhaustion, character-
ized by the persistent expression by lymphocytes of markers,
such as HLA-DR, CD25, PD-1 and CTLA-4. We determined
the expression of these molecules in both subpopulations of
GALT T-cells and compared it to that of peripheral blood T-
cells.
As shown in Figure 1A left, the frequency of CD4
+HLA-DR
+ T
cells in GALT was higher in untreated HIV-1-infected individuals
than in controls or HAART-treated patients (p,0.05). The
frequency of peripheral blood CD4
+HLA-DR
+ T-cells was higher
in both groups of HIV-1-infected individuals compared to controls
(median percentage: U: 14.9% vs C: 7.0%; p,0.05 and H: 17.2%
vs C: 7.0%; p,0.00; data not shown). The frequency of
CD8
+HLA-DR
+ T-cells in GALT was similar in the three groups
of individuals (Fig. 1A, right); in peripheral blood, it was higher in
untreated patients than in controls (U: 6.2% vs C: 2.4%; p,0.05),
but similar in controls and HAART-treated patients (data not
shown). The frequency of T-cells expressing CD25 showed similar
trends, and GALT T-cells from untreated patients exhibited the
highest expression (Fig. 1B, p,0.05). The frequency of CD25
+ T-
cells in PBMC was similar in all the groups (range 0.7-1.5%;
p=0.82, data not shown).
The frequency of GALT CD4
+ T-cells expressing CTLA-4 was
higher in both HIV-1-infected groups compared to controls, and
again the untreated group exhibited the highest values (U vs C;
p,0.05 and H vs C; p,0.001; see Table 2 and representative flow
cytometry data shown in Fig. 2A). Untreated patients also
exhibited the highest proportion of GALT CD8
+ T-cells
expressing CTLA-4 (U vs C; p,0.001 and U vs H; p,0.01;
Table 2). Expression of CTLA-4 by peripheral blood CD4
+ and
CD8
+ T-cells showed a trend similar to that observed in GALT
samples (data not shown).
When CTLA-4 levels were compared using mean fluorescence
intensities (MFI), untreated patients exhibited higher levels of
CTLA-4 in both subsets of GALT T-cells compared to controls
(p,0.001) and to the HAART-treated group (p,0.01; Fig. 2B). In
peripheral blood, CTLA-4, MFI in CD4
+ and CD8
+ T-cells
showed a trend similar to that of GALT (median MFI: 25, 3 and 2
in U, H and C respectively; both p,0.05).
The frequency of GALT CD4
+ T-cells expressing PD-1 was
significantly higher in both groups of HIV-1 infected individuals
than in controls, (U vs C; p,0.05 and H vs C; p,0.01; Table 2;
Table 1. Characteristics of healthy controls, HAART treated and untreated patients.
Healthy Controls (n=10) HAART Treated (n=13) Untreated (n=10)
Age (years)
1 45 (12) 44 (9) 35 (13)
% Female/Male 50/50 15/85 0/100
CD4
+ T cell counts (cell/mm
3)
2 905 (691–1093) 464 (301–1055) 337**(245–677)
CD8
+ T cell counts (cell/mm
3)
2 457 (310–618) 1127** (804–1605) 1451***(696–2038)
Viral load (copies/ml)
2 N/A 40 (40–223) 49430 ˆ (19119–88631)
1:results are expressed as mean (SE);
2: results are expressed as median (25th–75th percentiles). Groups were compared by the Kruskal-Wallis test and the Dunns multiple comparison post-test. Significant
differences are indicated by
**p,0.01,
***p,0.001. HIV-1 positive patients were compared by U Mann Whitney testˆ p,0.001. N/A: not applicable.
doi:10.1371/journal.pone.0030307.t001
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frequency of GALT CD8
+PD-1
+ T cells was also significantly
higher in HAART naı ¨ve compared to control cells (U vs C;
p,0.001; Table 2). In contrast, in peripheral blood, the
frequency of CD4
+ (range 2.6–4.9%) and CD8
+ (range 2.1–
2.5) T-cells expressing PD-1 was similar among the groups (data
not shown).
Since the levels of PD-1 per cell, rather than the percentage of
cells expressing PD-1, has been shown to correlate with T-cell
exhaustion [11,15], the PD-1 MFI was determined in all
compartments. PD-1 MFI in both GALT T-cell subsets was
higher in patients with higher viral load than in controls (p,0.001)
or treated patients (p,0.01; Fig. 3A and 3B). Similar data were
found for PD-1 MFI in peripheral blood T-cells (median MFI: 16,
4.5 and 3.5 for U, H and C, respectively; both p,0.01). To
evaluate the strength of the association between the T-cell
phenotype and viral load, correlations were examined in patients
with detectable viral load. Interestingly, the CTLA-4 MFI in
CD4
+ and CD8
+ T-cells from PBMC and GALT was positively
correlated with viral load (Fig. 4A and 4B). Similarly, the PD-1
MFI in CD4
+ T cells from the blood and GALT was positively
correlated with viral load (Fig. 4C). Similarly, a positive correlation
between the viral load and %CD8
+PD-1
+ (r=0.53; p=0.0008),
%CD4
+CTLA-4
+ (r=0.62; p=0.0016) and %CD8
+CTLA-4
+
(r=0.66; p=0.0005) on GALT was also observed. In contrast,
no significant relationships for VL and % PD-1/CTLA-4 T cells
in peripheral blood were seen.
Decreased expression of granzyme A by GALT CD8
+ T
cells from untreated patients
Granzyme A, a molecule associated with cytotoxic function, has
been shown to correlate with CD8 protective function [16]. The
frequency of granzyme A
+ CD8
+ T-cells was significantly lower in
PBMC (data not shown) and GALT from HAART naı ¨ve group
than in controls (Fig. 5A and 5B). Interestingly, normal frequency
of CD8
+ granzyme A
+ T-cells was observed in three untreated
individuals, who also exhibited the lowest viral load within this
group (,20,000 copies/ml). In fact, the frequency of CD8
+
granzyme A
+ T cells in blood or GALT was inversely correlated
with viral load (Fig. 5C).
Treg subsets are altered in GALT and blood of untreated
patients
Finally, to evaluate the potential variations of the CD4
+ T-cell
subpopulations in GALT, the mRNA expression of transcription
factors specific for Th1 (T-bet), Th2 (GATA-3), regulatory T-cells
(Treg; Foxp3), and for Th17 (ROR-ct) cells was measured. mRNA
Foxp3 expression in GALT was significantly increased in
untreated HIV-1-infected patients compared to HAART-treated
subjects and controls (U vs H; p,0.05 and U vs C; p,0.05;
Table 3). Expression of the other transcription factors was similar
among the groups (Table 3). Changes in Foxp3 expression led to
changes in the Foxp3/ROR-ct mRNA ratio, which was
significantly higher in the GALT of untreated patients compared
Figure 1. HIV-1 infected patients exhibit higher frequency of activation markers on rectal tissues. Phenotypic characterization of GALT
cells from healthy controls, HIV+ HAART-treated and untreated patients. A) Dot blot figures show the frequency of HLA-DR
+, and B) CD25
+ on CD4
+
(left panel) and CD8
+ (right panel) T-cells. Each bar represents the median of the data. Groups were compared by the Kruskal Wallis test and Dunn’s
multiple comparisons post-test. Significant differences are indicated by *p,0.05, **p,0.01, ***p,0001.
doi:10.1371/journal.pone.0030307.g001
Table 2. Frequency of CTLA-4
+ and PD-1
+ in T cells from GALT of healthy controls, HAART treated and untreated patients.
Frequency of T-cells Healthy Controls HAART Treated Untreated
%CD4
+CTLA
+ 4.74 (3.43–5.86) 12.74* (5.53–20.61) 28.07*** (19.76–44.16)
%CD8
+CTLA
+ 1.07 (0.36–1.92) 1.51 (1.26–2.28) 5.33***
++ (2.80–9.73)
%CD4
+PD-1
+ 7.75 (5.61–11.01) 19.38* (10.11–33.87) 36.13** (15.33–48.83)
%CD8
+PD-1
+ 11.17 (2.95–14.85) 9.05 (3.18–16.18) 23.97***(10.02–41.86)
The data are shown as median (25th percentile–75th percentile). Groups were compared by the Kruskal-Wallis test and the Dunns multiple comparison post-test.
Significant differences are indicated by
*p,0.05,
**p,0.01,
***p,0.001 compared to controls and
++p,0.01 compared with HAART treated group.
doi:10.1371/journal.pone.0030307.t002
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normalized this ratio, both in the GALT (Fig. 6A) and PBMC (not
shown). In addition, the GALT Foxp3/ROR-ct ratio was
positively correlated with viral load (r=0.472, p=0.035).
To corroborate our data, the expression of Foxp3 protein in
CD4
+ T cells was determined by flow cytometry in biopsies of
three individuals per group. As shown in the representative
figure 6B, the frequency of Treg (CD4
+Foxp3
+) was increased in
untreated patients compared to controls (U: 22,21% vs C: 8.26% ;
p,0.05) (data not shown). To rule out the possibility that the
increase of Foxp3 was due to cell activation rather that an increase
in Treg frequency, additional markers associated with Treg cell
phenotype were evaluated. The CD4
+Foxp3
+ cells were also
CD25
+ and CD127
Low/- (data not shown). Moreover, the Treg/
CD4
+ ratio in controls, HAART treated and untreated patients
was 1.01 (0.66–2.59), 3,89 (3.29–6.27) and 5.26 (3.48–9.32)
respectively. This ratio was significantly higher in untreated
patients compared with controls (U vs C; p,0.05). Although not
significant, in HAART treated patients the Treg frequency
(14.32%) and Treg/CD4
+ ratio were also increased. Unfortunate-
ly, it was not possible to detect IL-17 protein by flow cytometry.
Discussion
The GALT is an organ continually exposed to food and
microbial antigens, conditions that promote distinct functional
responses and phenotype of gut lymphocytes. During acute HIV-1
infection, viral replication induces severe immune and structural
damages in GALT, affecting the gut mucosal barrier, promoting
translocation of different microbial components to the systemic
circulation, which is considered as one of the main mechanisms
underlying chronic immune activation [17]. Since the pathophys-
iological findings that occur during HIV-1 infection have been
mainly characterized in circulating immune cells, we focused our
study on GALT T-cells. As previously reported [12,18], both the
proportion and the absolute numbers of CD4
+ T cells decreased in
the peripheral blood and GALT of HIV-1+ patients, including in
HAART-treated patients. This finding could be explained by
incomplete viral suppression in GALT [19], but it could be also
associated with the immune hyper-activation state exhibited by
HIV-1 infected individuals [20,21].
T-cell chronic activation induced by antigen persistence can
result in a functional unresponsive phenotype, known as immune
exhaustion [22]. This state is characterized by the loss of effector
functions such as proliferation, cytokine secretion and cytotoxic
activity [10,22,23]. T-cell exhaustion is observed during HIV-1
infection; and previous reports have shown higher levels of CTLA-
4 or PD-1 (protein or mRNA) on circulating CD4
+ and CD8
+ T-
cells from HIV-1 infected patients, compared to uninfected
individuals [10,14,24]. Here, we show that GALT CD4
+ and
CD8
+ T cells generally expressed higher expression of molecules
associated with exhaustion than peripheral T- cells, but this
upregulation was particularly striking in HIV-infected individuals.
Indeed, the frequency of PD-1 and CTLA-4-expressing T-cells
Figure 3. T-cells from untreated patients exhibit elevated expression of PD-1 in rectal tissues. A) Flow cytometry data from one
representative experiment with GALT samples from healthy controls, HIV+ HAART-treated and untreated patients are shown. Percentage of CD4
+PD-
1
+ cells and MFI is indicated in each panel. B) MFI of PD-1 in CD4
+ (left panel) and CD8
+ (right panel) T-cells from GALT.
doi:10.1371/journal.pone.0030307.g003
Figure 2. T-cells from untreated infected patients exhibit elevated expression of CTLA-4 in rectal tissues. A) Flow cytometry data from
one representative experiment with GALT samples from healthy controls, HIV+ treated and untreated patients are shown. Percentage of CD4
+CTLA-
4
+ cells and MFI is indicated in each panel. B) MFI of CTLA-4 on CD4
+ (left panel) and CD8
+ (right panel) T-cells from GALT.
doi:10.1371/journal.pone.0030307.g002
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four-fold higher in HIV-1-infected individuals, even after treat-
ment. Several mechanisms could explain these findings: i)
breakdown of the gastrointestinal mucosal barrier lead to
translocation of luminal lipopolysaccharide (LPS) and bacterial
DNA, triggering a sustained immune activation [17,25], and ii)
persistent exposure to HIV antigens drive this activation, which
could be particularly intense in the main sites of HIV replication
such as the GALT [22]. The second mechanism may be the most
important, as HIV-1- or SIV-specific CD8
+ T-cells are those
expressing the highest levels of PD-1 [26,27]. Our data also
supports such hypothesis as high frequencies of mucosal CD4
+ and
CD8
+ T-cells expressing CTLA-4 or PD-1 were detected in HIV-
1-infected patients with or without control of viral replication
compared to those seen in uninfected controls. Expression levels of
these molecules were also significantly higher in untreated patients.
Moreover, viral load was correlated with the expression of the
inhibitory molecules CTLA-4 and PD-1, suggesting a vicious cycle
where HIV-1 and immune alterations persist during the chronic
phase of infection.
Interestingly, the expression of PD-1 and CTLA-4 was always
higher in CD4
+ than in CD8
+ T- cells, suggesting the existence of
additional mechanisms inducing these molecules in CD4
+ T- cells.
These could include interactions with HIV-1-exposed dendritic
cells (DCs) or direct signaling by the HIV-1 Env proteins as both
pathways have been shown to induce PD-1 or CTLA-4 expression
[14,28]. Alternatively, the protein Nef induces PD-1 in HIV-1-
infected CD4
+ T-cells [29].
Similarly to a previous report [30], a strikingly low level of
granzyme A expression by peripheral and GALT CD8
+ T-cells
from HIV-1-infected patients was observed, particularly in
untreated patients. In contrast, other studies have reported an
increased expression of granzyme A by HIV-specific CD8
+ T-cells
in lymphoid tissues such as tonsils, lymph nodes and GALT from
untreated patients [16,31,32]. One possible explanation for this
apparent contradiction is the fact that the later studies recruited
only individuals expressing the HLA A*0201 allele, which is
associated with natural resistance to HIV-1 infection and slow
progression [33]. HAART partially normalized defective gran-
zyme expression, since the frequency of CD8
+ T-cells expressing
granzyme A was not significantly different in treated patients and
uninfected controls.
To further explore the cytokine profiles during HIV-1 infection,
we measured the expression of the transcription factors reported to
Figure 4. Phenotypic alterations in T-cells are modulated by HIV-1 viral load. Spearman correlation between plasma viral load and
phenotype of T cells from PBMC and GALT. Positive correlation between plasma viral load and CTLA-4 expression. A) In CD4
+ and B) CD8
+ T cells.
C) Positive correlation between viral load and PD-1 expression on CD4
+ T cells.
doi:10.1371/journal.pone.0030307.g004
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Foxp3 and ROR-ct that are expressed by Th1, Th2, Treg and
Th17 respectively. In most cases, a GALT Th17 response has
been associated with lower pathogenicity [34]. In contrast to
another study [35], we did not observe a decrease in Th17
expression in the GALT of HIV-infected patients. This difference
may have resulted from the low number of subjects enrolled in our
study and/or methodological differences, since the previous report
[35] evaluated the expression of IL-17 protein and we quantified
ROR-ct mRNA. One limitation of our approach is that it does not
allow analyzing the plasticity of the Treg and Th17 subsets, the
simultaneous expression of Foxp3 and ROR-ct molecules in some
cells [36,37]. Treg activation in presence of proinflammatory
cytokines induce the production of IL-17 [36,37]; therefore we
cannot rule out the possibility that the similar ROR-ct expression
in patients and controls is due to the increased frequency of Treg
exhibiting an intermediate differentiation profile (CD4
+CD25
Hi-
Foxp3
+ROR-ct
+) in the HIV-infected groups. This subpopulation
has not yet been reported in HIV-infected patients, and this would
deserve further investigation.
A higher Treg frequency was found in lymphoid tissues and
peripheral blood of HIV-1-infected patients, which was correlated
with disease progression in chronically infected patients
[13,14,38]. We found a change in the Foxp3/ROR-ct balance
in PBMC and GALT from the untreated patients, which was due
to increased Foxp3 RNA levels. Increased Foxp3 expression was
confirmed by flow cytometry. This result is in agreement with
previous reports [13,39], and supports the hypothesis that HIV-1
infection favors the Treg lineage. Mechanisms underlying such
changes are not well established, but could include Treg
expansion, migration, increased survival following CD4-gp120
interaction and/or peripheral non-Treg conversion, particularly in
the GALT [13,14]. Of note, PD-1 and CTLA-4 expression inhibit
IL-2 and IFN-c production but increase the enzyme indoleamine
2,3-dioxygenase (IDO) expression by DC [40,41,42], conditions
that would favor Treg polarization [13,43,44,45]. Further studies
are required to determine whether mucosal Treg are functional.
Of interest, Shaw et al recently showed accumulation of highly
activated Treg in rectal mucosal tissues, and that these cells were
suppressive [46].
Figure 5. Decreased expression of granzyme A by CD8
+ T cells in GALT from untreated patients. A) Flow cytometry data from one
representative experiment shows the frequency of CD8
+ granzyme A
+ from healthy controls, HAART-treated and untreated patients. B) Frequency of
total participants of CD8
+ granzyme A
+ in GALT. C) Frequency of CD8
+ granzyme A
+ T-cells was inversely correlated with viral load.
doi:10.1371/journal.pone.0030307.g005
Table 3. Expression of transcription factors in gastrointestinal tissue of controls, HAART treated and untreated patients.
Transcription factor Healthy Controls HAART Treated Untreated
Foxp3 0.006 (0.002–0.010) 0.005 (0.003–0.010) 0.029*
W (0.028–2.153)
ROR-ct 0.147 (0.070–0.325) 0.136 (0.0957–0.178) 0.166 (0.079–0.188)
T-bet 0.008 (0.005–0.0152) 0.009 (0.005–0.014) 0.027 (0.002–0.490)
GATA-3 0.129 (0.069–0.445) 0.160 (0.122–0.275) 0.034 (0.013–0.577)
Data are expressed as relative units after normalization on UB2D2 expression. Median (25th-75th percentiles) are shown for each transcription factors. Groups were
compared by the Kruskal–Wallis test and the Dunns multiple comparison post-test. Significant differences are indicated by *
W p,0.05 among untreated and controls (*)
and HAART treated (
W).
doi:10.1371/journal.pone.0030307.t003
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increased frequency of activated T cells, as a predictive value for
disease progression. However, although Treg appear fully
functional during HIV infection, as evidenced in suppressive
assays performed ex vivo [46,47,48,49], they are not able to
control excessive immune activation [39]. These data could be
explained by a so-far unrecognized deficit in Treg functionality.
Alternatively, it is possible that Treg frequency increases over time
to quell this ongoing inflammation [50], but is able to control it,
not abolish it. Interestingly, similar dynamic appears at play in
aging, in which increased frequency of functional Treg [51] does
not completely control the pro-inflammatory environment (the
"inflamm-aging") [52,53]. Future studies will be needed to clarify
this important issue.
In conclusion, our results suggest that expression of activation/
exhaustion markers by T cells is increased during HIV-1 infection,
particularly in the GALT, and is associated with increased
polarization towards a regulatory profile. These alterations are
not completely restored by HAART. Our findings thus imply that
other therapeutic strategies besides HAART will be necessary in
order to restore functional immune responses in the GALT of
HIV-infected patients.
Materials and Methods
Subjects and sample collection
Three groups of subjects, living in the metropolitan area from
Medellin-Colombia, were included in the study: healthy controls
(C, n=10), chronic HIV-1-infected patients on HAART treat-
ment (H, n=13), and untreated (U n=10) chronic HIV-1-infected
patients with viremia greater than 10,000 copies/ml. All the
patients have at least one year of HIV confirmed diagnosis.
The demographic and clinical characteristics of these individ-
uals are shown in Table 1. Absolute CD4
+ T-cell numbers were
calculated in whole blood samples. Plasma HIV-1 RNA levels
were assessed by RT-PCRq (COBAS AmpliPrep/COBAS Taq-
Man). All individuals signed an informed consent approved by the
Bioethical Board for Human Research of the University of
Antioquia, prepared according to the Colombian legislation
(Resolution 008430, 1993).
Isolation of cells from peripheral blood and GALT
Peripheral blood mononuclear cells (PBMC) were obtained
from 10 ml of heparin venous blood samples by centrifugation on
Histopaque (Sigma-Aldrich, St Louis, MO, USA) for 30 min at
400 x g. Rectal tissue was obtained by rectosigmoidoscopy from
the rectum at 10 cm from the anal verge. A flexible sigmoidoscope
with a single endoscopy biopsy forcep FB-24K-1 (Olimpus
America Corp, Melville, NY, USA) was used. At each procedure,
20 tissue samples of ,3 mm were obtained. Samples were
processed by digestion using collagenase type II from Clostridium
histolyticum (Sigma) at 0.5 mg/ml diluted in RPMI 1640 and 7.5%
FCS (fetal calf serum) (penicillin 100 U/ml, streptomycin 100 mg/
ml, amphotericine B 0.25 mg/ml) (Gibco-BRL; Grand Island, NY,
USA), during 30 min at 37uC while shaking. After collagenase
digestion, biopsy fragments were further disrupted by repeated
passage through a 30 ml syringe with a blunt ended 16 gauge
needle (Stem Cell Technologies, Vancouver, BC). Rectal cells
(RC) were isolated from the fragments by passage through a nylon
strainer of 70 mM (Falcon, Lincoln Park, NJ, USA). PBMC and
RC were washed with Dulbecos PBS (DPBS) (Sigma-Aldrich; St
Louis, MO, USA) to remove excess histopaque and collagenase.
Antibodies
The following anti-human monoclonal antibodies were used:
anti-CD4-ECD (clone SFCI12T4D11) (Beckman Coulter Full-
erton, CA, USA); anti-CD3-PE-CY7 (clone UCHT1); anti-HLA-
DR-PE (clone LN3); anti-CD25-PE-CY5 (clone BC96); anti-PD-1-
PE (CD 279, clone MIH4), anti-Foxp3-FITC (clone PCH101) (e-
Bioscience; San Diego, CA, USA); anti-CD3-FITC (clone
UCHT1); anti-CD4-PE-Cy5 (RPA-T4); anti-CD8-PE (RPA-T8);
anti-CTLA-4 PE (CD 152, clone BNI3) and anti-Granzyme A-PE
(clone MOPC-21) (BD Pharmingen; San Diego, CA, USA).
Appropriate isotype controls were used for each antibody.
Flow cytometric analysis of whole blood and isolated
rectal cells
For CD4+ T cell count, 100 ml of whole blood samples were
incubated for 30 min at 4uC with anti-CD3, anti-CD4 and anti-
CD8 monoclonal antibodies; red blood cells were eliminated by
lysis buffer (BD Biosciences) and washed twice with DPBS before
analysis by flow cytometry.
PBMC and RC were treated with 20 mg/ml of human IgG
(Sigma) to block Fc receptors, and stained on the surface with anti-
CD3, -CD4, -CD25 or -PD-1 for 30 min at 4C. The cells were
washed with DPBS, then fixed/permeabilized (Foxp3 staining
buffer kit, e-Bioscience) and stained intracellularly using mono-
clonal antibodies against CTLA-4, Foxp3 or granzyme A for
30 min at 4C. Also, the expression of activation markers such as
HLA-DR and CD38 was evaluated on whole blood samples using
Figure 6. Alteration of the expression of Foxp3 and ROR-ct ratio in cells from untreated patients. A) Relative units (RU) of ROR-ct and
Foxp3 mRNAs were measured by qRT-PCR. Whisker boxes figures show the ratio of RU of Foxp3/ROR-ct in GALT from healthy controls, HAART-
treated and untreated patients. B) Flow cytometry data from one representative experiment show the expression of Foxp3 on CD4
+ T cells in healthy
controls, HAART-treated and untreated patients.
doi:10.1371/journal.pone.0030307.g006
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acquired for each sample on the lymphocyte region, using the flow
cytometry FC500 (Beckman Coulter) and analyzed using the
Kaluza Software (Beckman Coulter). T-cells were gated first based
on forward- and side-scatter properties, then as CD3
+CD4
+ and
CD3
+CD8
+ cells. To define the limit of the positive gate, a CD3
-
population was used as negative reference; the MFI was analyzed
in the positive population.
Foxp3, ROR-ct, T-bet and GATA-3 mRNA expression
Rectal biopsies were placed in RNAlater (Qiagen, Inc.,
Valencia, CA, USA) and stored at 270uC for subsequent RNA
extraction. RNA was isolated with the quiazol reagent (Invitrogen
Corp., Carlsbad, CA, USA); 1 mg of RNA was used for
complementary DNA (cDNA) synthesis with RT-PCR using oligo
(dT) and random hexamers by the SuperScriptIII single stranded
cDNA synthesis kit (Invitrogen). The cDNA obtained was diluted
1:3 and used in quantitative RT-PCR reactions using SYBER
Green (qPCR Master Mix kit, Fermentas Life Sciences, Hanover,
MD, USA) with the following primers: Foxp3 (Forward: 5-
CAGCACATTCCCAGAGTTCCTC-3; Reverse: 5-GCGTGT-
GAACCAGTGGTAGATC-3); RORct (Forward: 5-TTTTCC-
GAGGATGAGATTGC-3; Reverse: 5- CTTTCCACATGC-
TGGCTACA-3); T-bet (Forward: 5-GCCTACAGAATGCCGA-
GATTACT-3; Reverse: 5-GGATGC TGGTGTCAACAGATG-
3), and GATA-3 (Forward: 5-GCG GGCTCTATCACAA-
AATGA-3; Reverse: 5-GCTCTCCTGGCTGCAGACAGC-3
(Integrated DNA Technologies (IDT) Coralville, IA, USA) [54].
Expression levels were normalized by Dct using ubiquitin-
conjugating enzyme (UBE2D2) as housekeeping gene [55]
(Forward: 5-AGCTACAATAATGGGGCCAA-3; Reverse: 5-
TGAAGGGGTAATCTGTTGGG-3) (IDT) and expressed such
as relative units (RU).
Statistical Analysis
Statistical analyses were done using GraphPad Prism 5 (San
Diego, CA, USA). Comparisons of medians among groups were
performed by the Wilcoxon or Kruskal-Wallis test and Dunns
post-test. Correlation was made with spearman test, p values lower
than 0.05 were considered statistically significant.
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